GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/14/2026 6:12:20 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $3,648 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 5/5/2026 3:31:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $3,873 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 2/11/2026 12:54:38 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $14,098 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 11/10/2025 4:34:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $4,323 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/5/2025 7:22:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $53,277 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/24/2025 5:33:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $25,175 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/24/2025 5:33:56 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $31,974 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/23/2025 2:44:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $38,676 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/23/2025 2:34:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $45,281 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/22/2025 4:05:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $50,792 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/18/2025 5:34:53 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $58,459 | EPS -$0.15 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/11/2025 10:06:47 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $19,027 | EPS -$0.03 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/14/2023 2:58:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $539,148 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/2/2023 1:07:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $656,937 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 7/21/2023 12:47:05 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $658,500 -45.0% | Assets $687,486 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 11/21/2022 3:54:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $643,648 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/12/2022 4:34:02 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $669,331 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 5/16/2022 12:48:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $298,500 +200.0% | Assets $728,594 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 4/15/2022 3:59:33 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $1,197,500 +74.1% | Assets $761,077 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 11/22/2021 3:14:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $629,828 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/23/2021 3:11:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $500,000 | Assets $700,365 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 5/24/2021 3:35:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $99,500 -85.5% | Assets $938,874 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 4/2/2021 5:15:14 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $687,964 -49.2% | Assets $998,053 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 11/17/2020 3:43:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $989,107 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/19/2020 5:03:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $998,293 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 5/19/2020 1:05:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $687,964 -49.2% | Assets $1,019,449 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 3/27/2020 3:09:41 PM | Micro | View | Financials | 10-KT | SEC | Y 2019 ending: 12/31/2019 | Rev: $1,354,000 -83.1% | Assets $1,069,464 | EPS -$0.01 | |
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 1/7/2020 1:03:37 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 9/30/2019 | Rev: $1,354,000 -83.1% | Assets $1,069,464 | EPS -$0.01 | |
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/14/2019 2:35:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 6/30/2019 | Assets $1,081,094 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 5/15/2019 2:58:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 3/31/2019 | Assets $1,139,469 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 2/14/2019 7:10:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 12/31/2018 | Rev: $1,354,000 -6.3% | Assets $1,270,935 | ||
| Acro Biomedical Co., Ltd. (ACBM) | 12/28/2018 4:02:52 PM | View | Financials | Earnings | WIRE | Y 2018 | Export Earnings Model | ||||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 12/28/2018 1:46:43 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 9/30/2018 | Rev: $8,014,500 +1,471.5% | Assets $1,482,829 | EPS $0.01 | |
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/14/2018 4:09:50 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 6/30/2018 | Rev: $2,199,000 | Assets $1,010,107 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/1/2018 5:26:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 3/31/2018 | Rev: $1,964,000 | Assets $867,923 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 2/14/2018 7:47:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 12/31/2017 | Rev: $1,445,000 | Assets $764,534 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 1/16/2018 5:16:36 PM | Micro | View | Financials | 10-K/A | SEC | Y 2017 ending: 9/30/2017 | Rev: $510,000 | Assets $548,310 | ||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 8/11/2017 3:43:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 6/30/2017 | Assets $2,500 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 5/22/2017 1:13:02 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 3/31/2017 | Assets $2,000 | |||
| ACRO BIOMEDICAL CO., LTD. (ACBM) | 2/14/2017 3:36:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 12/31/2016 | Assets $2,391 | |||
| KILLER WAVES HAWAII, INC (ACBM) | 12/16/2016 4:51:42 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 9/30/2016 | Assets $2,533 | |||
| KILLER WAVES HAWAII, INC (ACBM) | 8/3/2016 1:55:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 6/30/2016 | Assets $2,341 | |||
| KILLER WAVES HAWAII, INC (ACBM) | 5/13/2016 8:23:04 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 3/31/2016 | Assets $11,742 |